{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:10:20Z","timestamp":1784232620259,"version":"3.55.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>The proton pump inhibitors are widely prescribed for the symptomatic treatment of chronic epigastric pain and heartburn in cancer patients, but they carry the potential for drug\u2013drug interactions (DDI) with oral antineoplastic agents. In this retrospective cohort study, we examine the utility of 24-hour esophageal and gastric ambulatory pH monitoring off- or on-proton pump inhibitors (PPI) therapy as a guide in safely prescribing of PPI for cancer patients. We analyzed data from 189 consecutive non-cancer patients with chronic PPI-refractory gastroesophageal reflux disease (GERD) 146 (75F\/71M) \u2018off\u2019 and 39 (21F\/18M) \u2018on\u2019 PPIs; 4 (2F\/2M) had atrophic gastritis and were used as controls. There were 69 with pathologic esophageal acid reflux and 74 patients with normal esophageal acid exposure. The 24-hour % gastric pH &amp;lt;4 in these two groups that exhibited median values of 92% and 89%, respectively (NS). Gastric acidity was highest in non-PPI users (median 92.8%), less in PPI users (median 40.8%), and near absent (median 1.65%) in patients with atrophic gastritis (P\u00a0&amp;lt;\u2009.005). In 39 patients who underwent 24-hour intragastric pH monitoring \u2018on\u2019 PPI, the best times to administer a drug that needs acidity for optimal bioavailability are 3\u00a0pm\u20136\u00a0pm and 3\u00a0am\u20136\u00a0am, and better with daily v. twice- daily PPI. We conclude that dual esophageal and gastric pH monitoring, identifies (a) the presence of pathologic esophageal acid reflux, justifying long-term PPI use; (b) the absence of pathologic esophageal reflux negating PPI use; (c) the presence of variable levels of PPI-induced gastric hypochlorhydria; (d) time-windows of gastric pH\u2009&amp;lt;\u20094 that would optimize other drug coadministration for maximal oncologic drug bioavailability.<\/jats:p>","DOI":"10.1093\/dote\/doag073","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:44:39Z","timestamp":1784231079000},"source":"Crossref","is-referenced-by-count":0,"title":["Lessons learned: use of 24-hour ambulatory esophageal and gastric pH monitoring and its implications for proton pump inhibitor use in cancer patients requiring oral oncologic therapies"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-3773","authenticated-orcid":false,"given":"George","family":"Triadafilopoulos","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The University of Texas MD Anderson Cancer Center , Conroe, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"5","key":"2026071615443013400_ref1","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S1470-2045(20)30069-3","article-title":"Clinical implications of food\u2013drug interactions with small-molecule kinase inhibitors","volume":"21","author":"Veerman","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"2026071615443013400_ref2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamaoncol.2016.3323","article-title":"Drug-drug interactions with oral antineoplastic agents","volume":"3","author":"Parsad","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026071615443013400_ref3","doi-asserted-by":"publisher","first-page":"102794","DOI":"10.1016\/j.ctrv.2024.102794","article-title":"Proton pump inhibitors and cancer treatments: emerging evidence against coadministration","volume":"129","author":"Raoul","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"2026071615443013400_ref4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1442-2050.2012.01381.x","article-title":"Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy","volume":"26","author":"Galindo","year":"2013","journal-title":"Dis Esophagus"},{"issue":"7","key":"2026071615443013400_ref5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"},{"key":"2026071615443013400_ref6","doi-asserted-by":"publisher","first-page":"doaf102","DOI":"10.1093\/dote\/doaf102","article-title":"Lessons learned: endoscopy with 96-hour ambulatory esophageal pH monitoring as a tool to avoid proton pump inhibitor use in cancer patients with refractory gastroesophageal reflux","volume":"38","author":"Triadafilopoulos","year":"2025","journal-title":"Dis Esophagus"},{"issue":"8","key":"2026071615443013400_ref7","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s10620-019-05940-9","article-title":"Ninety-six hour wireless esophageal pH study in patients with GERD shows that restrictive diet reduces esophageal acid exposure","volume":"65","author":"Triadafilopoulos","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"6","key":"2026071615443013400_ref8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowthduring proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/4\/doag073\/69070674\/doag073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/39\/4\/doag073\/69070674\/doag073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:44:40Z","timestamp":1784231080000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doag073\/8736012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doag073","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"doag073"}}